Aardvark Therapeutics, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, 92122
Mailing Address 4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, 92122
Phone (858) 225-7696
Fiscal Year End 1231
EIN 821606367
Financial Overview
FY2025
-$20.59M
Net Income
$117.18M
Total Assets
$10.55M
Total Liabilities
$106.63M
Stockholders' Equity
$61.64M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 24, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 10-K Annual financial report | March 23, 2026 | View on SEC |
| 8-K Current report of material events | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 10, 2026 | View on SEC |
Annual Reports
10-K March 23, 2026
- Trades on The Nasdaq Stock Market LLC under ticker AARD, providing market visibility and liquidity.
- Classified as an 'emerging growth company' and 'smaller reporting company,' indicating growth potential and reduced regulatory burden.
Material Events
8-K Strategy Change March 23, 2026
High Impact
- Strong financial position with $110.0 million in cash and investments as of December 31, 2025.
- Cash runway extends into mid-2027, providing crucial financial breathing room to navigate challenges.
Insider Trading
BUY 2 insiders
2 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.